This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
The article shows how different indices measure market breadth and why breadth trends matter for identifying trend strength and potential reversals.
27,800 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Ripple’s RLUSD has reached three major exchanges—Gate, Binance, and OKX—accelerating its trajectory as a regulated do...
As valuations run high, retirement plans face tighter assumptions. Experts urge conservative return targets and diver...
A coordinated effort by Fannie Mae and Freddie Mac aims to reduce borrowing costs for homeowners. This article explai...
Two iconic ETFs sit at opposite ends of the market-cap spectrum. One tracks big, established giants; the other captur...
Two big market events could move stocks this month. Learn how a Federal Reserve decision and the latest inflation and...
SpaceX has sparked huge investor curiosity, but buying SpaceX stock before the next move requires a disciplined plan....
A JPMorgan note argues that a U.S. crypto market structure bill could pass by June and act as a positive catalyst for...
A JPMorgan client note argues that Strategy may purchase as much as $30 billion of Bitcoin in 2026, placing Bitcoin i...
The first half of 2026 delivered a housing market that steadied into a new normal. Here are the five lessons that def...
Micron has surged into a market-defining position as traders weigh earnings potential against memory-price risk. Anal...
Deloitte issued an independent accountant’s report on Anchorage Digital Bank’s USAT Reserve Report, marking a milesto...